ACG Inspection to Open New Center of Excellence in Switzerland
The new location will handle logistics, development, data, service support, FAT, and project management.
ACG Inspection, a division of ACG, an integrated pharma manufacturing solutions company, announced it will open a new “Centre of Excellence” in Yverdon, Switzerland for logistics, development, data, service support, factory acceptance test (FAT), and project management for the company.
The company will host a three-day “open doors” celebration to welcome customers and media to the Yverdon location, according to an Oct. 8, 2019 press release. The event will feature live technology demonstrations of its future-ready technologies including, Brand Protection, Geo-Location Identification, Process Analytical Technology (PAT), Industrial Internet of Things (IIoT), Temperature Monitoring, Inspection 4.0 (AI Powered), and End-To-End Tracentication.
“Our new ‘Centre of Excellence’ will allow the team to create adaptive solutions in response to customer needs and requirements-helping to make them future-ready,” said Ettore Cucchetti, CEO, ACG Inspection, in the press release. “It is set to be a hub of R&D in the region, with aims to discover new technologies for serialization, aggregation, PAT, blister inspection, authentication, and track & trace solutions (including geo-localization and temperature monitoring). We will subsequently be moving in a new business and assembly premises for Europe of about 1000 m2. This facility is planned to be ready by the end of 2020.”
ACG will be exhibiting at Booth 102A40 at CPhI Worldwide, taking place Nov. 5–7, 2019 in Frankfurt, Germany.
Source: ACG
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
